MiMedx Group, Inc. Analyst EPS Estimates
Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
---|---|---|---|---|
Q1 2024 | 0 | $0.04 | $0.05 | $0.05 |
Q2 2024 | 0 | $0.07 | $0.08 | $0.08 |
Q3 2024 | 3 | $0.04 | $0.05 | $0.05 |
Q4 2024 | 0 | $0.05 | $0.06 | $0.06 |
Q1 2025 | 2 | $0.07 | $0.07 | $0.07 |
Q2 2025 | 2 | $0.09 | $0.09 | $0.09 |
Q3 2025 | 2 | $0.07 | $0.07 | $0.07 |
Q4 2025 | 2 | $0.09 | $0.09 | $0.09 |
MiMedx Group, Inc. Earnings Date And Information
MiMedx Group, Inc. last posted its earnings results on Wednesday, July 31st, 2024. The company reported $0.08 earnings per share for the quarter, missing analysts' consensus estimates of $0.08 by $0. The company had revenue of 87.21 M for the quarter and had revenue of 321.48 M for the year. MiMedx Group, Inc. has generated $0 earnings per share over the last year ($0.32 diluted earnings per share) and currently has a price-to-earnings ratio of 8.92. MiMedx Group, Inc. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Monday, October 28th, 2024 based on prior year's report dates.
MiMedx Group, Inc. Earnings History by Quarter
Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
---|---|---|---|---|---|---|
07/31/2024 | Q2 2024 | $0.08 | $0.12 | 0.04 | $89.01 M | $87.21 M |
04/30/2024 | Q1 2024 | $0.05 | $0.06 | 0.01 | $84.71 M | |
02/28/2024 | Q4 2023 | $0.08 | $0.43 | 0.35 | $86.83 M | |
10/30/2023 | Q3 2023 | $0.05 | $0.06 | 0.01 | $76.87 M | $81.71 M |
08/01/2023 | Q2 2023 | $0.01 | -$0.00 | -0.01 | $74.84 M | $81.26 M |
05/02/2023 | Q1 2023 | -$0.09 | -$0.04 | 0.05 | $71.68 M | |
05/01/2023 | Q4 2022 | -$0.00 | $74.38 M | |||
11/02/2022 | Q3 2022 | -$0.09 | -$0.08 | 0.01 | $66.73 M | $67.69 M |
08/02/2022 | Q2 2022 | -$0.06 | -$0.10 | -0.04 | $65.07 M | $66.88 M |
05/03/2022 | Q1 2022 | -$0.10 | -$0.10 | 0 | $58.89 M | |
02/28/2022 | Q4 2021 | $0.00 | $0.01 | 0.01 | $67.41 M | |
11/02/2021 | Q3 2021 | -$0.08 | -$0.02 | 0.06 | $60.26 M | $63.07 M |
08/03/2021 | Q2 2021 | -$0.07 | -$0.02 | 0.05 | $58.77 M | $68.17 M |
04/28/2021 | Q1 2021 | -$0.19 | -$0.08 | 0.11 | $59.97 M | |
03/08/2021 | Q4 2020 | -$0.05 | -$0.16 | -0.11 | $68.55 M | |
11/04/2020 | Q3 2020 | -$0.18 | $64.30 M | |||
08/04/2020 | Q2 2020 | -$0.08 | $53.65 M | |||
07/06/2020 | Q1 2020 | -$0.04 | $61.74 M | |||
07/06/2020 | Q4 2019 | -$0.07 | $76.40 M | |||
07/06/2020 | Q3 2019 | $0.12 | $117.89 M | $88.86 M |
MiMedx Group, Inc. Earnings: Frequently Asked Questions
-
When is MiMedx Group, Inc.'s earnings date?
MiMedx Group, Inc. has not confirmed its next earnings publication date, but the company's estimated earnings date is Monday, October 28th, 2024 based off last year's report dates.
-
How can I listen to MiMedx Group, Inc.'s earnings conference call?
The conference call for MiMedx Group, Inc.'s latest earnings report can be listened to online.
-
How can I read MiMedx Group, Inc.'s conference call transcript?
The conference call transcript for MiMedx Group, Inc.'s latest earnings report can be read online.
-
How much revenue does MiMedx Group, Inc. generate each year?
MiMedx Group, Inc. (:MDXG) has a recorded annual revenue of $321.48 M.
-
How much profit does MiMedx Group, Inc. generate each year?
MiMedx Group, Inc. (:MDXG) has a recorded net income of $321.48 M. MiMedx Group, Inc. has generated $0.4 earnings per share over the last four quarters.
-
What is MiMedx Group, Inc.'s price-to-earnings ratio?
MiMedx Group, Inc. (:MDXG) has a price-to-earnings ratio of 8.92 and price/earnings-to-growth ratio is 3.33.